Product Information
CEFEPIME HCL 2 GRAM VIAL is a generic product labeled by Hospira Inc., priced at $5.3480 per EA under NDC 00409973510. Its NADAC has been published 22 times since Nov 20, 2024.
FDA first approved this application on Mar 20, 2008. Its Orange Book therapeutic-equivalence code is AP.
Strength
2 g/1
Manufacturer
Hospira Inc.NDC
00409973510
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
3/19/2025
Active Ingredients
CEFEPIME HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065441FDA Approved
3/20/2008
TE Code
AP
On Market Since
8/24/2020
Pharmacological Classes
Price Statistics
The NADAC for CEFEPIME HCL 2 GRAM VIAL has been published 22 times since Nov 20, 2024, and over the history we have for it it has declined 3.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.3480 per EA |
|---|---|
| All-time high | $5.5636 (Dec 11, 2024) |
| All-time low | $5.3480 (Mar 19, 2025) |
| Median price | $5.5424 |
| Average price | $5.4847 |
| Largest weekly change | -1.8% (Feb 19, 2025) |
| Weeks tracked | 22 |
| Tracking since | Nov 20, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-3.9%
Last surveyed Apr 16, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFEPIME HCL 2 GRAM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFEPIME HCL 2 GRAM VIAL, manufactured by Hospira Inc., is $5.3480 per EA (NDC 00409973510), effective Apr 16, 2025.
How has the price of CEFEPIME HCL 2 GRAM VIAL changed over time?
Over the history we have for it, the NADAC for CEFEPIME HCL 2 GRAM VIAL has declined 3.9%. It has been tracked across 22 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for CEFEPIME HCL 2 GRAM VIAL?
Since Nov 20, 2024, the NADAC for CEFEPIME HCL 2 GRAM VIAL has ranged from a low of $5.3480 (Mar 19, 2025) to a high of $5.5636 (Dec 11, 2024), with a median of $5.5424 per EA.
Are there cheaper alternatives to CEFEPIME HCL 2 GRAM VIAL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFEPIME HCL 2 GRAM VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFEPIME HCL 2 GRAM VIAL?
CEFEPIME HCL 2 GRAM VIAL (NDC 00409973510) is labeled by Hospira Inc., and CMS classifies it as a generic product.